A guide to critical reading of influenza vaccine cost-effectiveness analyses
Global and Regional Health Technology Assessment · 27.04.2026 · 13 (1) · 95-108
DOI: 10.33393/grhta.2026.3619 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Global and Regional Health Technology Assessment, online erschienen am 27.04.2026. Verfasst von Raúl Ortiz de Lejarazu und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Influenza Centre of Valladolid, Valladolid - Spain. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Influenza vaccines are formulated each year to prevent serious illness in at-risk individuals, includingelderly people. Healthcare decision-making is mainly based on the economic evaluations (EEs) (i.e., costeffectivenessanalysis [CEA]) of vaccines; however, understanding the limitations of these models and correctlyinterpreting the results may be challenging. Here, we provide a practical Guide that will help readers who are notexperts in the field of health economics or influenza to critically review influenza vaccine EEs.
Methods
This Guide is based on the findings of a systematic review of the literature, a critical analysis of theavailable EEs published for influenza vaccines for older adults in Spain, and applicable national and internationalguidelines on EE and influenza modeling. It has been developed by a multidisciplinary board of experts in influenza,vaccines, and health economics.
Results
The guide provides tips to help the reader assess whether an EE design is fit for its purpose in terms ofcomparators, time horizon, perspective of the analysis, population analyzed, and whether appropriate modelingmethods were applied. It detects the uncertainty arising from input data and the implications of this uncertaintyon the results.
Conclusions
Ultimately, this resource aims to empower decision-makers, particularly those without expertise inhealth economics or vaccinology, to critically read and interpret EEs, thus favoring evidence-based informed decisionsthat will improve the efficiency of influenza vaccination programs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Influenza Centre of Valladolid, Valladolid - Spain.
- International Healthcare Centre of Ayuntamiento de Madrid, Madrid - Spain.
- CIBER of Respiratory Diseases (CIBERES), Instituto de Salud Carlos III, Madrid - Spain.
- Preventive and Public Health Department, Rey Juan Carlos University, Madrid - Spain.
- Translational Paediatrics and Infectious Diseases Section, Paediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela - Spain.
- Vaccines, Infections and Pediatrics Research Group (GENVIP), Healthcare Research Institute of Santiago de Compostela, Santiago de Compostela - Spain.
ORCID-Profile: Raúl Ortiz de Lejarazu, Esther Redondo Margüello, Federico Martinón Torres, J Manel Farré Avellà, José M Abellán Perpiñán
Zitieren
APA
Ortiz de Lejarazu, R., Redondo Margüello, E., Gil de Miguel, Á., Martinón Torres, F., Domingo, J. D., López-Belmonte Claver, J. L., Díaz-Aguiló, A., Farré Avellà, J. M., Palomo Jiménez, P. I., & Abellán Perpiñán, J. M. (2026). A guide to critical reading of influenza vaccine cost-effectiveness analyses. Global and Regional Health Technology Assessment, 13(1), 95-108. https://doi.org/10.33393/grhta.2026.3619
Vancouver
Ortiz de Lejarazu R, Redondo Margüello E, Gil de Miguel Á, Martinón Torres F, Domingo JD, López-Belmonte Claver JL, et al. A guide to critical reading of influenza vaccine cost-effectiveness analyses. Global and Regional Health Technology Assessment. 2026;13(1):95-108. doi:10.33393/grhta.2026.3619
BibTeX
@article{OrtizdeLejarazu2026,
author = {Ortiz de Lejarazu, Raúl and Redondo Margüello, Esther and Gil de Miguel, Ángel and Martinón Torres, Federico and Domingo, Javier Díez and López-Belmonte Claver, Juan L and Díaz-Aguiló, Ariadna and Farré Avellà, J Manel and Palomo Jiménez, Paloma I and Abellán Perpiñán, José M},
title = {A guide to critical reading of influenza vaccine cost-effectiveness analyses},
journal = {Global and Regional Health Technology Assessment},
year = {2026},
volume = {13},
number = {1},
pages = {95--108},
doi = {10.33393/grhta.2026.3619}
}
EUVIMED